Phase 3 Study of ProstAtak™ With Standard Radiation Therapy for Localized Prostate Cancer (PrTK03)
This study is currently recruiting participants.
Verified February 2013 by Advantagene, Inc.
Sponsor:
Advantagene, Inc.
Information provided by (Responsible Party):
Advantagene, Inc.
ClinicalTrials.gov Identifier:
NCT01436968
First received: September 19, 2011
Last updated: February 22, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | September 2015 (Final data collection date for primary outcome measure) |